Minocycline for Controlling Neuropathic Pain: A Systematic Narrative Review of Studies in Humans

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2021 Feb 4

PMID 33536779

Citations 16

Authors

Dong Ah Shin

Tae Uk Kim

Min Cheol Chang

Affiliations

Soon will be listed here.

Abstract

Objective: Minocycline is known to reduce microglial activation, suggesting that it may reduce neuropathic pain. We reviewed studies in humans that evaluated the effectiveness of minocycline in alleviating neuropathic pain.

Methods: We searched the PubMed, Embase, Cochrane library, and SCOPUS databases for papers published before January 06, 2021, using the search words minocycline and pain. The inclusion criteria for the selection of articles were (1) minocycline administered to humans and (2) minocycline administered to control neuropathic pain.

Results: The primary literature search yielded 2299 relevant papers. Based on the assessment of the titles, abstracts, and full-text, nine publications were selected for this review. Only four of the nine studies showed a positive pain-reducing outcome after minocycline administration. Two of the three studies on chemotherapy-induced neuropathic pain showed a positive pain-reducing effect. Minocycline was effective in controlling pain from diabetic and leprotic neuropathies. However, minocycline was not effective in controlling lumbar radicular pain and pain resolution after carpal tunnel release.

Conclusion: Our review provides evidence that minocycline may have some potential for reducing neuropathic pain. Further high-quality studies need to be conducted to validate this potential.

Citing Articles

Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review.

Candan B, Gungor S Diagnostics (Basel). 2025; 15(3).

PMID: 39941283 PMC: 11817358. DOI: 10.3390/diagnostics15030353.

Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review.

Moradi F, Mokhtari T J Biochem Mol Toxicol. 2025; 39(2):e70071.

PMID: 39853846 PMC: 11798427. DOI: 10.1002/jbt.70071.

Mechanisms and Therapeutic Prospects of Microglia-Astrocyte Interactions in Neuropathic Pain Following Spinal Cord Injury.

Liu Y, Cai X, Shi B, Mo Y, Zhang J, Luo W Mol Neurobiol. 2024; 62(4):4654-4676.

PMID: 39470872 DOI: 10.1007/s12035-024-04562-1.

Minocycline Abrogates Individual Differences in Nerve Injury-Evoked Affective Disturbances in Male Rats and Prevents Associated Supraspinal Neuroinflammation.

OBrien J, Austin P J Neuroimmune Pharmacol. 2024; 19(1):30.

PMID: 38878098 PMC: 11180027. DOI: 10.1007/s11481-024-10132-y.

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies.

Magni G, Riboldi B, Ceruti S Cells. 2024; 13(7.

PMID: 38607045 PMC: 11011741. DOI: 10.3390/cells13070606.

References

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

Cho H, Kang J, Kim S, Choi M, Hwang S, Cho Y . Changes in Neuroglial Activity in Multiple Spinal Segments after Caudal Epidural Pulsed Radiofrequency in a Rat Model of Lumbar Disc Herniation. Pain Physician. 2016; 19(8):E1197-E1209. View

Martinez V, Szekely B, Lemarie J, Martin F, Gentili M, Ben Ammar S . The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: a randomized, double-blind, controlled study. Pain. 2013; 154(8):1197-203. DOI: 10.1016/j.pain.2013.03.028. View

Zhao H, Alam A, Chen Q, A Eusman M, Pal A, Eguchi S . The role of microglia in the pathobiology of neuropathic pain development: what do we know?. Br J Anaesth. 2017; 118(4):504-516. DOI: 10.1093/bja/aex006. View

Kraus R, Pasieczny R, Lariosa-Willingham K, Turner M, Jiang A, Trauger J . Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem. 2005; 94(3):819-27. DOI: 10.1111/j.1471-4159.2005.03219.x. View

Pachman D, Dockter T, Zekan P, Fruth B, Ruddy K, Ta L . A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. Support Care Cancer. 2017; 25(11):3407-3416. DOI: 10.1007/s00520-017-3760-2. View

Jang S, Chang M . At Least 5-Year Follow-up After Transforaminal Epidural Steroid Injection Due to Lumbar Radicular Pain Caused by Spinal Stenosis. Pain Pract. 2020; 20(7):748-751. DOI: 10.1111/papr.12905. View

Garrido-Mesa N, Zarzuelo A, Galvez J . Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013; 169(2):337-52. PMC: 3651660. DOI: 10.1111/bph.12139. View

Vanelderen P, Van Zundert J, Kozicz T, Puylaert M, de Vooght P, Mestrum R . Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Anesthesiology. 2014; 122(2):399-406. DOI: 10.1097/ALN.0000000000000508. View

10.

Syngle A, Verma I, Krishan P, Garg N, Syngle V . Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study. Neurol Sci. 2014; 35(7):1067-73. DOI: 10.1007/s10072-014-1647-2. View

11.

Sumitani M, Ueda H, Hozumi J, Inoue R, Yamada Y, Kogure T . Minocycline Does Not Decrease Intensity of Neuropathic Pain Intensity, But Does Improve Its Affective Dimension. J Pain Palliat Care Pharmacother. 2015; 30(1):31-5. DOI: 10.3109/15360288.2014.1003674. View

12.

Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson A, Yarnitsky D . Neuropathic pain. Nat Rev Dis Primers. 2017; 3:17002. PMC: 5371025. DOI: 10.1038/nrdp.2017.2. View

13.

Sun J, Yang Y, Zhang Y, Huang W, Li Z, Zhang Y . Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol Med Rep. 2015; 12(2):2677-82. DOI: 10.3892/mmr.2015.3735. View

14.

Shultz R, Zhong Y . Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen Res. 2017; 12(5):702-713. PMC: 5461601. DOI: 10.4103/1673-5374.206633. View

15.

Wang X, Shi Q, Bhadkamkar N, Cleeland C, Garcia-Gonzalez A, Aguilar J . Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage. 2019; 58(4):662-671. PMC: 6754803. DOI: 10.1016/j.jpainsymman.2019.06.018. View

16.

Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman E . Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep. 2016; 16(3):29. PMC: 5127166. DOI: 10.1007/s11892-016-0727-5. View

17.

Curtin C, Kenney D, Suarez P, Hentz V, Hernandez-Boussard T, Mackey S . A Double-Blind Placebo Randomized Controlled Trial of Minocycline to Reduce Pain After Carpal Tunnel and Trigger Finger Release. J Hand Surg Am. 2017; 42(3):166-174. DOI: 10.1016/j.jhsa.2016.12.011. View

18.

Narang T, Arshdeep , Dogra S . Minocycline in leprosy patients with recent onset clinical nerve function impairment. Dermatol Ther. 2016; 30(1). DOI: 10.1111/dth.12404. View

19.

Majidi J, Kosari-Nasab M, Salari A . Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice. Brain Res Bull. 2015; 120:1-13. DOI: 10.1016/j.brainresbull.2015.10.009. View

20.

Chang M . Efficacy of Pulsed Radiofrequency Stimulation in Patients with Peripheral Neuropathic Pain: A Narrative Review. Pain Physician. 2018; 21(3):E225-E234. View